主动脉夹层后血压管理的研究进展

李志勇; 王晶; 周雅丽; 袁东

doi:10.12290/xhyxzz.2023-0643

主动脉夹层后血压管理的研究进展

doi: 10.12290/xhyxzz.2023-0643

李志勇^1, ,,
王晶²,
周雅丽³,
袁东¹

1. 兰州大学第二医院血管外科, 兰州 730030;
2. 兰州大学第二医院健康管理中心, 兰州 730030;
3. 兰州大学第二医院萃英生物医学研究中心, 兰州 730030

基金项目:

甘肃省自然科学基金(21JR11RA121)；甘肃省高校创新基金(2021B-046)

详细信息

通讯作者:
李志勇,E-mail:332541047@qq.com

中图分类号: R543.1;R544.1
计量
- 文章访问数: 18
- HTML全文浏览量: 5
- PDF下载量: 3
- 被引次数: 0
出版历程
- 网络出版日期: 2024-04-19

Research Progress in Blood Pressure Management after Aortic Dissection

1. Vascular Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China;
2. Healthy Examinnation & Management Center, Lanzhou University Second Hospital, Lanzhou 730030, China;
3. Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou 730030, China

Funds:

Gansu Provincial Natural Science Foundation (21JR11RA121)； Gansu Province University Innovation Fund (2021B-046)

摘要

摘要: 高血压（hypertension， HT）可通过增加主动脉管壁张力和促使组织结构退化而诱发主动脉夹层（aortic dissection， AD），是 AD 预后的显著影响因素，也是最重要的可控因素。研究表明， AD 后血压管理可降低 AD 发病率及死亡率，因此控制 HT 是 AD 治疗的重要目标和手段，目前，血压管理的方式主要包括调整生活方式、药物治疗、手术治疗。本文就 AD 对血压的影响、 AD 后血压管理的意义及方式相关研究进展进行综述，为 AD 患者的治疗提供参考，使患者从中获益。
- 高血压 /
- 主动脉夹层 /
- 血压管理
Abstract: Hypertension (HT) can induce aortic dissection (AD) by increasing the tension of the aortic wall and promoting tissue degradation. It is a significant prognostic factor for AD and the most important controllable factor. Research shows that blood pressure management after AD can reduce the incidence rate and mortality of AD, so controlling HT is an important goal and means of AD treatment. At present, blood pressure management mainly includes lifestyle adjustment, drug treatment, and surgical treatment. This article reviews the research progress on the impact of AD on blood pressure, the significance and methods of blood pressure management after AD, providing reference for the treatment of AD patients and benefiting them.
- hypertension /
- aortic dissection /
- blood pressure management

HTML全文

参考文献(78)

[1]	Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[published correction appears in Hypertension. 2018 Jun;71(6):e140-e144]. Hypertension. 2018;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065
[2]	Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases:lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899-1911.doi: 10.1016/S0140-6736(14)60685-1
[3]	Eggebrecht H, Schmermund A, von Birgelen C, et al. Resistant hypertension in patients with chronic aortic dissection. J Hum Hypertens. 2005;19(3):227-231. doi: 10.1038/sj.jhh.1001800
[4]	Bossone E, Eagle KA. Epidemiology and management of aortic disease:aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021;18(5):331-348. doi: 10.1038/s41569-020-00472-6
[5]	Thomas N. Hypertensive Management. Crit Care Nurs Clin North Am. 2023;35(1):31-38. doi: 10.1016/j.cnc.2022.11.001
[6]	Nienaber CA, Yuan X. Taming Hypertension to Prevent Aortic Dissection:Universal Recognition of a "New Normal" Blood Pressure?. Circulation. 2022;145(9):645-647. doi: 10.1161/CIRCULATIONAHA.121.058133
[7]	Evangelista, A.Isselbacher EM, Bossone E, et al. Insights From the International Registry of Acute Aortic Dissection:A 20-Year Experience of Collaborative Clinical Researc h. Circulation. 2018;137(17):1846-1860. doi: 10.1161/CIRCULATIONAHA.117.031264
[8]	Shalaeva EV, Messerli FH. What is resistant arterial hypertension?. Blood Press. 2023;32(1):2185457. doi: 10.1080/08037051.2023.218545
[9]	Patel KV, Li X, Kondamudi N, et al. Prevalence of Apparent Treatment-Resistant Hype rtension in the United States According to the 2017 High Blood Pressure Guideline. Mayo Clin Proc. 2019;94(5):776-782. doi: 10.1016/j.mayocp.2018.12.033
[10]	Januzzi JL, Sabatine MS, Choi JC, et al. Refractory systemic hypertension following type B aortic dissection. Am J Cardiol. 2001;88(6):686-688. doi: 10.1016/s0002-9149(01)01818-5
[11]	Koracevic G, Lovic D, Zdravkovic M, et al. Long-lasting, resistant hypertension should be a part of the aortic dissection risk score. Hypertens Res. 2019;42(11):1836-1838. doi: 10.1038/s41440-019-0305-8
[12]	Erbel R, Aboyans V, Boileau C, et al. ESC Committee for Practice Guidelines. 2014 E SC Guidelines on the diagnosis and treatment of aortic diseases:document covering ac ute and chroni-c aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treat-ment of Aortic Diseases of the European Socie ty of Cardiology (ESC). Eur Heart J. 2014;35:2873-926. https://doi.org/10.1093/eurheart j/ehu281
[13]	Li A, Mohetaer D, Zhao Q, et al. The Relationship Between Renal Artery Involvement in Stanford B-Type Aortic Dissection and the Short-Term Prognosis:A Single-Centre Retrospective Cohort Study. Heart Lung Circ. 2019;28(8):1261-1266. doi: 10.1016/j.hlc.2018.07.002
[14]	Ge YP, Li CN, Li Y, et al. Relationship Between Renal Function and Renal Artery Involvement in Acute Debakey Type I Aortic Dissection. Heart Surg Forum. 2020;23(4):E465-E469. Published 2020 Jul 7. doi: 10.1532/hsf.3023
[15]	van Bakel PAJ, Henry M, Kim KM, et al. Imaging features of renal malperfusion in aortic dissection. Eur J Cardiothorac Surg. 2022;61(4):805-813. doi: 10.1093/ejcts/ezab555
[16]	Lin Y, Chen Y, Peng Y, et al. Symptoms of post-traumatic stress disorder and associated risk factors in type A aortic dissection. J Cardiovasc Surg (Torino). 2021;62(3):286-293. doi: 10.23736/S0021-9509.21.11553-8
[17]	Blakeslee-Carter J, Menon AJ, Novak Z, et al. Association of Mental Health Disorders and Aortic Dissection. Ann Vasc Surg. 2021;77:217-225. doi: 10.1016/j.avsg.2021.05.054
[18]	Camafort M, Ihm SH, Ruilope LM. Renal denervation for the treatment of hypertension and kidney disease. Curr Opin Nephrol Hypertens. 2023;32(6):544-550. doi: 10.1097/MNH.0000000000000928
[19]	Tseilikman V, Komelkova M, Kondashevskaya MV, et al. A Rat Model of Post-Traumatic Stress Syndrome Causes Phenotype-Associated Morphological Changes and Hypofunction of the Adrenal Gland. Int J Mol Sci. 2021;22(24):13235. Published 2021 Dec 8. doi: 10.3390/ijms222413235
[20]	Reed AB, Faizer R, James Valentine R. The impact of pre-existing blood pressure control in patients with acute aortic dissections. Vascular. 2022;30(6):1051-1057. doi: 10.1177/17085381211042152
[21]	Otaki Y, Watanabe T, Konta T, et al. Effect of Hypertension on Aortic Artery Disease-Related Mortality-3.8-Year Nationwide Community-Based Prospective Cohort Study. Circ J. 2018;82(11):2776-2782. doi: 10.1253/circj.CJ-18-0721
[22]	Kimura N, Aizawa K, Kawahito K, et al. Outcomes of Early-Onset Acute Type A Aortic Dissection-Influence of Etiologic Factors. Circ J. 2019;83(2):285-294. doi: 10.1253/circj.CJ-18-0969
[23]	Gawinecka J, Schönrath F, von Eckardstein A. Acute aortic dissection:pathogenesis, risk factors and diagnosis. Swiss Med Wkly. 2017;147:w14489. https://doi.org/10.4414/smw.2017. 14489
[24]	Song C, Yu G, Feng X, et al. Impact of high blood pressure variability on the occurrence of acute type B aortic dissection. Vascular. 2020;28(4):413-420. doi: 10.1177/1708538120902630
[25]	Zhang L, Tian W, Feng R, et al. Prognostic Impact of Blood Pressure Variability on Aortic Dissection Patients After Endovascular Therapy. Medicine (Baltimore). 2015;94(38):e1591. doi: 10.1097/MD.0000000000001591
[26]	Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability:classic and novel measurement techniques. Nat Rev Cardiol. 2022;19(10):643-654. doi: 10.1038/s41569-022-00690-0
[27]	Jana S, Hu M, Shen M, Kassiri Z. Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm. Exp Mol Med. 2019;51:1-15. doi: 10.1038/s12276-019-0286-3
[28]	Lewis CE, Fine LJ, Beddhu S, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384:1921-1930. doi: 10.1056/NEJMoa1901281
[29]	Ribeiro F, Teixeira M, Alves AJ, et al. Lifestyle Medicine as a Treatment for Resistant Hypertension. Curr Hypertens Rep. 2023;25(10):313-328. doi: 10.1007/s11906-023-01253-5
[30]	Carey RM, Muntner P, Bosworth HB, et al. Prevention and Control of Hypertension:JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(11):1278-1293. doi: 10.1016/j.jacc.2018.07.008
[31]	Xie H, Li J, Zhu X, et al. Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients:a prospective cohort study of UK Biobank. Cardiovasc Diabetol. 2022;21(1):199. Published 2022 Oct 1. doi: 10.1186/s12933-022-01632-3
[32]	Blumenthal JA, Hinderliter AL, Smith PJ, et al. Effects of Lifestyle Modification on Patients With Resistant Hypertension:Results of the TRIUMPH Randomized Clinical Trial. Circulation. 2021;144(15):1212-1226. doi: 10.1161/CIRCULATIONAHA.121.055329
[33]	Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents[published correction appears in Pediatrics. 2017 Nov 30;:] [published correction appears in Pediatrics. 2018 Sep;142(3):]. Pediatrics. 2017;140(3):e20171904. doi: 10.1542/peds.2017-1904
[34]	Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease:A Scientific Statement From the American Heart Association[published correction appears in Circulation. 2022 Mar 22;145(12):e775]. Circulation. 2021;144(3):e56-e67. doi: 10.1161/CIR.0000000000000988
[35]	Perger E, Pengo MF, Lombardi C. Hypertension and atrial fibrillation in obstructive sleep apnea:Is it a menopause issue?. Maturitas. 2019;124:32-34. doi: 10.1016/j.maturitas.2019.02.012
[36]	Akashiba T, Inoue Y, Uchimura N, et al. Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020. Respir Investig. 2022;60(1):3-32. doi: 10.1016/j.resinv.2021.08.010
[37]	Iida H, Kurita N, Takahashi S, et al. Salt intake and body weight correlate with higher blood pressure in the very elderly population:The Sukagawa study. J Clin Hypertens (Greenwich). 2019;21(7):942-949. doi: 10.1111/jch.13593
[38]	Huggins CE, Margerison C, Worsley A, Nowson CA. Influence of dietary modifications on the blood pressure response to antihypertensive medication. Br J Nutr. 2011;105(2):248-255. doi: 10.1017/S0007114510003223
[39]	Akhlaghi M. Dietary Approaches to Stop Hypertension (DASH):potential mechanisms of action against risk factors of the metabolic syndrome. Nutr Res Rev. 2020;33(1):1-18. doi: 10.1017/S0954422419000155
[40]	Middlekauff HR, Cooper ZD, Strauss SB. Drugs of Misuse:Focus on Vascular Dysfunction. Can J Cardiol. 2022;38(9):1364-1377. doi: 10.1016/j.cjca.2022.04.011
[41]	Isselbacher EM,Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease:A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106
[42]	Chaddha A, Erickson S, Kline-Rogers E, et al. Medication adherence patterns in aortic dissection survivors. Indian J Med Res. 2018;147(2):183-188. doi: 10.4103/ijmr.IJMR_1198_15
[43]	Ishiyama Y, Hoshide S, Mizuno H, et al. Constipation-induced pressor effects as triggers for cardiovascular events. J Clin Hypertens (Greenwich). 2019;21(3):421-425. doi: 10.1111/jch.13489
[44]	Tehrani AY, White Z, Milad N, et al. Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan. Physiol Rep. 2021;9(10):e14877. doi: 10.14814/phy2.14877
[45]	Hofmann Bowman MA, Eagle KA, Milewicz DM. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome:A Review. JAMA Cardiol. 2019;4(7):702-707. doi: 10.1001/jamacardio.2019.1176
[46]	Strauss MH, Hall AS, Narkiewicz K. The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases. Cardiovasc Drugs Ther. 2023;37(4):757-770. doi: 10.1007/s10557-021-07248-1
[47]	Gao Q, Xu L, Cai J. New drug targets for hypertension:A literature review. Biochim Biophys Acta Mol Basis Dis. 2021;1867(3):166037. doi: 10.1016/j.bbadis.2020.166037
[48]	Filippone EJ, Naccarelli GV, Foy AJ. Controversies in Hypertension V:Resistant and Refractory Hypertension. Am J Med. 2024;137(1):12-22. doi: 10.1016/j.amjmed.2023.09.015
[49]	Peacock E, Krousel-Wood M. Adherence to Antihypertensive Therapy. Med Clin North Am. 2017;101(1):229-245. doi: 10.1016/j.mcna.2016.08.005
[50]	Tajeu GS, Kent ST, Kronish IM, et al. Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012. Hypertension. 2016;68(3):565-575. doi: 10.1161/HYPERTENSIONAHA.116.07720
[51]	Gwadry-Sridhar FH, Manias E, Lal L, et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension:a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health. 2013;16(5):863-871. doi: 10.1016/j.jval.2013.03.1631
[52]	Martin G, Patel N, Grant Y, et al. Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate. J Vasc Surg. 2018;68(3):693-699.e2. doi: 10.1016/j.jvs.2017.12.063
[53]	Usai MV, Nugroho NT, Oberhuber A,et al. Influence of TEVAR on blood pressure in subacute type B aortic dissection (TBAD) patients with refractory and non-refractory arterial hypertension. Int Angiol. 2021;40(1):60-66. doi: 10.23736/S0392-9590.20.04433-8
[54]	Deshpande AA, Pandey NN, Shaw M, et al. Evaluation of Remodeling of Visceral Arteries and Impact on Renal Function Post-endovascular Repair of Type B Aortic Dissection Vis-A-Vis Baseline Visceral Artery Morphology. Vasc Endovascular Surg. 2022;56(6):553-560. doi: 10.1177/15385744221090906
[55]	Wang L, Lin M, Yu J, et al. The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure:Systematic Review and Meta-Analysis. Obes Surg. 2021;31(11):4970-4984. doi: 10.1007/s11695-021-05671-9
[56]	Sénéchal-Dumais I, Auclair A, Leclerc J, et al. Effect of bariatric surgery on blood pressure response to exercise in a severely obese population. Blood Press Monit. 2021;26(5):357-363. doi: 10.1097/MBP.0000000000000543
[57]	Hawkins DN, Faler BJ, Choi YU, et al. Time Course of Blood Pressure Decrease After Bariatric Surgery in Normotensive and Hypertensive Patients. Obes Surg. 2018;28(7):1845-1851. doi: 10.1007/s11695-017-3091-x
[58]	Pang KP, Pang EB, Pang KA, et al. Upper airway surgery for obstructive sleep apnea reduces blood pressure. Laryngoscope. 2018;128(2):523-527. doi: 10.1002/lary.26759
[59]	Lim JH, Park P, Wee JH, et al. Evaluation of the success of obstructive sleep apnea surgery using criteria based on long-term symptoms and incident hypertension. Eur Arch Otorhinolaryngol. 2018;275(4):1015-1022. doi: 10.1007/s00405-018-4894-7
[60]	Akashiba T, Inoue Y, Uchimura N, et al. Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020. Respir Investig. 2022;60(1):3-32. doi: 10.1016/j.resinv.2021.08.010
[61]	Akinseye OA, Ralston WF, Johnson KC, et al. Renal Sympathetic Denervation:A Comprehensive Review. Curr Probl Cardiol. 2021;46(3):100598. doi: 10.1016/j.cpcardiol.2020.100598
[62]	Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension. Am J Cardiol. 2010;105(4):570-576. doi: 10.1016/j.amjcard.2009.10.027
[63]	Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension:a pilot study. Circulation. 2011;123(18):1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869
[64]	García-Touchard A, Maranillo E, Mompeo B, et al. Microdissection of the Human Renal Nervous System:Implications for Performing Renal Denervation Procedures. Hypertension. 2020;76(4):1240-1246. doi: 10.1161/HYPERTENSIONAHA.120.15106
[65]	Divchev D, Turan G, Rehders T, et al. Renal sympathetic denervation in patients with aortic dissection. J Interv Cardiol. 2014;27(3):334-339. doi: 10.1111/joic.12110
[66]	Trimarchi S, Eagle KA, Nienaber CA, et al. Importance of refractory pain and hypertension in acute type B aortic dissection:insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2010;122(13):1283-1289. doi: 10.1161/CIRCULATIONAHA.109.929422
[67]	Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol. 2011;58(11):1176-1182. doi: 10.1016/j.jacc.2011.05.036
[68]	Lenski D, Kindermann I, Lenski M, et al. Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. EuroIntervention. 2013;9(6):700-708. doi: 10.4244/EIJV9I6A114
[69]	Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea:Randomized Proof-of-Concept Phase II Trial. Hypertension. 2018;72(2):381-390. doi: 10.1161/HYPERTENSIONAHA.118.11180
[70]	Rao A, Krishnan N. Update on Renal Sympathetic Denervation for the Treatment of Hypertension. Curr Cardiol Rep. 2022;24(10):1261-1271. doi: 10.1007/s11886-022-01753-x
[71]	Ke F, Kuang W, Hu X, et al. A novel vaccine targeting β1-adrenergic receptor. Hypertens Res. 2023;46(6):1582-1595. doi: 10.1038/s41440-023-01265-3
[72]	Li C, Yan X, Wu D, et al. Vaccine Targeted Alpha 1D-Adrenergic Receptor for Hypertension. Hypertension. 2019;74(6):1551-1562. doi: 10.1161/HYPERTENSIONAHA.119.13700
[73]	Kurashiki T, Miyake T, Nakagami H, et al. Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model. Hypertension. 2020;76(6):1879-1888. doi: 10.1161/HYPERTENSIONAHA.119.14442
[74]	Zhang H, Liao M, Cao M, et al. ATRQβ-001 Vaccine Prevents Experimental Abdominal Aortic Aneurysms. J Am Heart Assoc. 2019;8(18):e012341. doi: 10.1161/JAHA.119.012341
[75]	Chyu KY, Zhao X, Zhou J, et al. Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis. JCI Insight. 2022;7(11):e149741. Published 2022 Jun 8. doi: 10.1172/jci.insight.149741
[76]	Natsis M, Antza C, Doundoulakis I, et al. Hypertension in Obesity:Novel Insights. Curr Hypertens Rev. 2020;16(1):30-36. doi: 10.2174/1573402115666190415154603
[77]	Wang F, Zhang Z, Fang A, et al. Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis. Front Immunol. 2019;9:3127. Published 2019 Jan 10. doi: 10.3389/fimmu.2018.03127
[78]	Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases:document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873-2926. https://doi.org/10.1093/eurheartj/ehu281

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 18
HTML全文浏览量: 5
PDF下载量: 3
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

地址：	北京市东城区帅府园1号北京协和医院老楼7号楼 3层302室《协和医学杂志》编辑部
电话：	010-69154261/4262
E - mail：	medj@pumch.cn mjpumch@126.com
期刊网站版权所有：	《协和医学杂志》编辑部京ICP备 11002662

留言板

主动脉夹层后血压管理的研究进展

doi: 10.12290/xhyxzz.2023-0643

通讯作者:
李志勇,E-mail:332541047@qq.com

计量

Research Progress in Blood Pressure Management after Aortic Dissection

计量

目录

留言板

主动脉夹层后血压管理的研究进展

doi: 10.12290/xhyxzz.2023-0643

通讯作者: 李志勇,E-mail:332541047@qq.com

计量

出版历程

Research Progress in Blood Pressure Management after Aortic Dissection

计量

出版历程

目录

通讯作者:
李志勇,E-mail:332541047@qq.com